Will anyone in the 340B Fight Will Say Who the Money Serves?

Washington can trace the prescription, the rebate, the manufacturer, and the covered entity. The trail stops at the patient.

Rojas actual,

There is a war on right now over the 340B rebate model. HRSA wants manufacturers to hold the discount and pay it back later.

The hospital lobby wants to keep taking it upfront.
A bipartisan Senate bill wants to lock the upfront model in place.

Watch the three of them argue, and you’ll notice the same thing I did: not one of them will tell you who the money is for.

That silence is the whole story.